B
Biocube Inc
OTC:BICB
Biocube Inc
OTC:BICB
Price:
0.0001
USD
Market Closed
Market Cap:
$9.7k
Balance Sheet
Balance Sheet Decomposition
Biocube Inc
Biocube Inc
Balance Sheet Decomposition is not available for
Biocube Inc
Biocube Inc
Balance Sheet
Biocube Inc
Biocube Inc
Currency: USD
| Jan-2008 | Jan-2009 | Jan-2010 | Jan-2011 | Jan-2012 | Jan-2013 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
2
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
2
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
3
-27%
|
0
-96%
|
0
-74%
|
0
-95%
|
0
-79%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
2
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
4
|
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
4
+62%
|
0
-97%
|
1
+775%
|
1
-6%
|
1
+20%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
6
|
10
|
0
|
1
|
1
|
2
|
|
| Additional Paid In Capital |
8
|
8
|
0
|
0
|
0
|
1
|
|
| Other Equity |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
1
N/A
|
0
+99%
|
1
-10 658%
|
1
+4%
|
1
-21%
|
|
| Total Liabilities & Equity |
4
N/A
|
3
-27%
|
0
-96%
|
0
-74%
|
0
-95%
|
0
-79%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
2
|
2
|
20
|
29
|
29
|
50
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
